VINANTE, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 6.582
EU - Europa 5.981
AS - Asia 2.622
SA - Sud America 69
AF - Africa 18
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.291
Nazione #
US - Stati Uniti d'America 6.538
GB - Regno Unito 2.445
CN - Cina 1.616
SG - Singapore 727
IT - Italia 550
SE - Svezia 524
FR - Francia 510
RU - Federazione Russa 466
IE - Irlanda 448
DE - Germania 408
FI - Finlandia 372
UA - Ucraina 151
JP - Giappone 70
BR - Brasile 51
TR - Turchia 44
CA - Canada 38
VN - Vietnam 37
BE - Belgio 34
IR - Iran 29
IN - India 23
KR - Corea 18
NL - Olanda 13
ID - Indonesia 12
CZ - Repubblica Ceca 11
AU - Australia 9
HK - Hong Kong 9
LT - Lituania 6
PL - Polonia 6
SC - Seychelles 6
CH - Svizzera 5
CL - Cile 5
EU - Europa 5
LV - Lettonia 5
PK - Pakistan 5
AR - Argentina 4
CO - Colombia 4
MA - Marocco 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AL - Albania 3
AT - Austria 3
BD - Bangladesh 3
BG - Bulgaria 3
JO - Giordania 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CM - Camerun 2
CR - Costa Rica 2
ES - Italia 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NO - Norvegia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
EC - Ecuador 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MS - Montserrat 1
MY - Malesia 1
PS - Palestinian Territory 1
UZ - Uzbekistan 1
Totale 15.291
Città #
Southend 2.242
Jacksonville 1.362
Chandler 938
Woodbridge 715
Ashburn 620
Singapore 583
Houston 545
Dublin 445
Ann Arbor 390
Wilmington 200
Beijing 186
Lawrence 173
Princeton 173
Jinan 162
Shenyang 162
Nanjing 160
Verona 124
Sindelfingen 98
New York 88
Hebei 86
Zhengzhou 75
Tianjin 68
Changsha 65
Boardman 61
Helsinki 56
Nanchang 56
Taizhou 56
Haikou 54
Ningbo 52
Jiaxing 45
Hangzhou 42
Guangzhou 38
Milan 36
Brussels 34
Taiyuan 34
Lancaster 32
Falls Church 29
Fairfield 24
Norwalk 24
Seattle 24
Moscow 23
San Francisco 23
Fuzhou 22
Redmond 22
Santa Clara 22
Dong Ket 21
Lanzhou 19
Lonigo 19
Columbus 17
Dearborn 17
Düsseldorf 17
Kent 17
Toronto 17
Bologna 16
Los Angeles 16
Rome 15
Washington 15
Auburn Hills 14
Redwood City 13
Kochi 12
Philadelphia 12
Jakarta 11
Leawood 11
Kemerovo 10
Dallas 9
Zanjan 9
Clearwater 8
London 8
Seongbuk-gu 8
Seoul 8
Shinchiba 8
Ardabil 7
Paris 7
São Paulo 7
Tsukuba 7
Ankara 6
Châtenay-Malabry 6
Hong Kong 6
Mahé 6
Ypsilanti 6
Buffalo 5
Cambridge 5
Edinburgh 5
Melbourne 5
Montréal 5
Sacramento 5
San Diego 5
Tappahannock 5
Tokyo 5
Verdun 5
Brno 4
Chicago 4
Cossato 4
Frankfurt am Main 4
Genoa 4
Groningen 4
Montreal 4
Orsogna 4
Ottawa 4
Qingdao 4
Totale 10.964
Nome #
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 357
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 329
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 160
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 158
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 156
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 145
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 141
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 132
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 130
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 127
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia 126
L'alfa interferone nei pazienti con Hairy Cell Leukemia attiva il sistema NK, ma non induce un'attività citotossica specifica verso le cellule hairy 125
I marcatori delle cellule linfoidi 125
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 124
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 122
Immunologic abnormalities in angioimmunoblastic lymphadenopathy 122
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 122
α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib 122
Biological prognostic factors in indolent lymphoma 121
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 121
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 120
Leucemie 115
A study of the crosstalk between CD30 and CXCR4 115
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 115
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 114
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 114
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 114
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis 114
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 114
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 113
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 112
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 111
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin 111
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 110
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 110
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 109
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 109
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells 109
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 108
Immunophenotypic approach to the detection of minimal residual disease in acute leukemia 107
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 107
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 107
The Sesquiterpene Oil {alpha}-Bisabolol Induces Apoptosis of B-Chronic Lymphocytic Leukemia Primary Cells 105
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 102
Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-cell chronic lymphocytic leukemia. 101
Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia 101
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders 100
Gram-negative septicemia in patients with hematologic malignancies 100
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis 99
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders 99
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 98
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 97
Origin of the soluble interleukin 2 receptor in the serum of patients with hairy cell leukemia 97
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 96
AML blasts express heparin-binding epidermal growth factor-like growth factor (HB-EGF)/diphtheria toxin receptor 96
Soluble molecules as biological markers in Hodgkin's disease 95
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 95
Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases 95
Studio immunologico delle popolazioni linfoidi normali nella leucemia acuta mieloide in remissione completa. Evidenze di un possibile controllo immunologico della ricaduta 95
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 95
CD30 e assetto citochinico dei linfociti T, valutato mediante analisi citofluorimetrica, in un caso di sindrome da iper-IgE asintomatica 93
Differential expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia. 93
Sesquiterpene α-bisabolol, which binds to Bid in lipid rafts, induces apoptosis in BCR/ABL+ cell lines through membrane depolarization. 93
Il recettore per l'interleuchina-2 sulle cellule normali e neoplastiche 92
Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms 91
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 91
Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40 91
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 91
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease 90
CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540. 90
Thymic epithelial cell-derived interleukin-7 promotes survival of human T-cell acute lymphoblastic leukemia 90
Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines 89
The CD4 molecule belongs to the phenotypic repertoire of most cases of acute myeloid leukemia 88
ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease 88
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 88
CD30+ L540 cells express CCR5 and CXCR4 molecules, CCR3 mRNA and release RANTES and MIP-1alfa 86
High serum levels of soluble interleukin-2 receptors in sarcoidosis 86
Granulocyte-macrophage colony-stimulating factor induces expression of heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor and sensitivity to diphtheria toxin in human neutrophils 86
L'immunofenotipo nelle leucemie 85
Role for IFN-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. 85
Presence of interleukin-2 receptor gamma chain transcript in AML blasts [letter] 84
Functional analysis of cytotoxic cells in patients with acute nonlymphoblastic leukemia in complete remission 84
Progressive polarization towards a Th(c)1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration 84
Empiric therapy of infections in hematologic malignancies: a prospective randomized trial 84
JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia 84
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS 83
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 83
Mitochondrial-Mediated Apoptosis by the Sesquiterpene Oil {alpha}-Bisabolol and Its Synergism with Imatinib and Nilotinib In BCR-ABL+ Cells. 83
Serum levels of soluble CD30 in chronic hepatitis type B 83
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 83
Activation of Protein Tyrosine Phosphatase Receptor Type γ Suppresses Mechanisms of Adhesion and Survival in Chronic Lymphocytic Leukemia Cells 83
Le molecole solubili in oncoematologia 82
Rearrangement for the T-cell receptor gene and co-expression of immature T-cell markers and natural killer cell phenotype, in a patient with acute lymphoblastic leukaemia 82
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 82
CD30 antigen and cellular biology of Reed-Sternberg cells [letter; comment] 81
CD30 antigen and cellular biology of Reed-Sternberg cells 81
Soluble molecules in lymphoproliferative diseases 81
Role of CD30 molecule in HIV-1 infection 79
Correlation between soluble interleukin-2 receptor and neoplastic bulk in hairy cell leukemia 79
Membrane and soluble antigens and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 79
Totale 10.719
Categoria #
all - tutte 47.682
article - articoli 32.329
book - libri 0
conference - conferenze 13.487
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.866
Totale 95.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020952 0 0 0 0 0 0 154 184 89 193 86 246
2020/20211.716 132 262 80 174 177 219 15 162 144 16 250 85
2021/20221.641 125 522 13 92 109 48 37 77 51 80 170 317
2022/20232.836 229 247 254 539 243 716 14 165 311 27 58 33
2023/20241.573 66 113 162 152 173 209 105 292 10 26 159 106
2024/20251.414 216 248 106 577 167 98 2 0 0 0 0 0
Totale 15.446